Novartis Pharmaceuticals Canada Inc
- A10 - Antidiabéticos
- STARLIX film-coated tablet 120 mg
- STARLIX film-coated tablet 60 mg
- C01 - Terapia cardíaca
- TRANSDERM NITRO RETARD transdermal patch 0.2 mg/h
- TRANSDERM NITRO RETARD transdermal patch 0.4 mg/h
- TRANSDERM NITRO RETARD transdermal patch 0.6 mg/h
- C07 - Betabloqueantes
- LOPRESOR film-coated tablet 100 mg
- LOPRESOR film-coated tablet 50 mg
- LOPRESOR prolonged-release tablet 100 mg
- LOPRESOR prolonged-release tablet 200 mg
- LOPRESOR solution for injection 5 mg/5 ml
- VISKAZIDE tablet 10 mg+25 mg
- VISKAZIDE tablet 10 mg+50 mg
- VISKEN tablet 10 mg
- VISKEN tablet 15 mg
- VISKEN tablet 5 mg
- C09 - Agentes activos sobre el sistema renina-angiotensina
- DIOVAN capsule, hard 160 mg
- DIOVAN capsule, hard 80 mg
- DIOVAN HCT film-coated tablet 160 mg+12.5 mg
- DIOVAN HCT film-coated tablet 160 mg+25 mg
- DIOVAN HCT film-coated tablet 320 mg+12.5 mg
- DIOVAN HCT film-coated tablet 320 mg+25 mg
- DIOVAN HCT film-coated tablet 80 mg+12.5 mg
- DIOVAN tablet 160 mg
- DIOVAN tablet 320 mg
- DIOVAN tablet 40 mg
- DIOVAN tablet 80 mg
- ENTRESTO film-coated tablet 103 mg+97 mg
- ENTRESTO film-coated tablet 49 mg+51 mg
- LOTENSIN tablet 20 mg
- LOTENSIN tablet 5 mg
- RASILEZ film-coated tablet 150 mg
- RASILEZ film-coated tablet 300 mg
- RASILEZ HCT film-coated tablet 150 mg+12.5 mg
- RASILEZ HCT film-coated tablet 150 mg+25 mg
- RASILEZ HCT film-coated tablet 300 mg+12.5 mg
- RASILEZ HCT film-coated tablet 300 mg+25 mg
- C10 - Agentes modificadores de los lípidos
- LESCOL capsule, hard 20 mg
- LESCOL capsule, hard 40 mg
- LESCOL prolonged-release tablet 80 mg
- D01 - Antifúngicos para uso dermatológico
- LAMISIL cream 1%
- LAMISIL cutaneous spray, solution 1%
- LAMISIL tablet 250 mg
- D07 - Preparados dermatológicos con corticosteroides
- VIOFORM HYDROCORTISONE cream 1%+3%
- G03 - Hormonas sexuales y moduladores del sistema genital
- ESTALIS transdermal patch 50 µg/24 h+140 µg/24 h
- ESTALIS transdermal patch 50 µg/24 h+250 µg/24 h
- H01 - Hormonas hipofisiarias, hipotalámicas y análogos
- SANDOSTATIN LAR powder and solvent for suspension for injection 10 mg+2 ml
- SANDOSTATIN LAR powder and solvent for suspension for injection 20 mg+2 ml
- SANDOSTATIN LAR powder and solvent for suspension for injection 30 mg+2 ml
- SANDOSTATIN solution for injection 1 000 µg/5 ml
- SANDOSTATIN solution for injection 100 µg/1 ml
- SANDOSTATIN solution for injection 50 µg/1 ml
- SANDOSTATIN solution for injection 500 µg/1 ml
- SIGNIFOR solution for injection 0.3 mg/1 ml
- SIGNIFOR solution for injection 0.6 mg/1 ml
- SIGNIFOR solution for injection 0.9 mg/1 ml
- J01 - Antibacterianos para uso sistémico
- TOBI nebuliser solution 300 mg/5 ml
- TOBI PODHALER inhalation powder, hard capsule 28 mg
- J05 - Antivirales de uso sistémico
- FAMVIR film-coated tablet 125 mg
- FAMVIR film-coated tablet 250 mg
- FAMVIR film-coated tablet 500 mg
- SEBIVO film-coated tablet 600 mg
- L01 - Antineoplásicos
- AFINITOR DISPERZ soluble tablet 2 mg
- AFINITOR DISPERZ soluble tablet 3 mg
- AFINITOR DISPERZ soluble tablet 5 mg
- AFINITOR tablet 10 mg
- AFINITOR tablet 2.5 mg
- AFINITOR tablet 5 mg
- GLEEVEC tablet 100 mg
- GLEEVEC tablet 400 mg
- JAKAVI tablet 10 mg
- JAKAVI tablet 15 mg
- JAKAVI tablet 20 mg
- JAKAVI tablet 5 mg
- TASIGNA capsule, hard 150 mg
- TASIGNA capsule, hard 200 mg
- ZYKADIA capsule, hard 150 mg
- L02 - Terapia endocrina
- FEMARA tablet 2.5 mg
- L03 - Inmunoestimulantes
- EXTAVIA powder and solvent for solution for injection 0.3 mg(9.6 M IU)+1.2 ml
- PROLEUKIN powder for solution for injection 22 M IU
- L04 - Inmunosupresores
- GILENYA capsule, hard 0.5 mg
- ILARIS powder for solution for injection 150 mg
- MYFORTIC gastro-resistant tablet 180 mg
- MYFORTIC gastro-resistant tablet 360 mg
- NEORAL capsule, soft 10 mg
- NEORAL capsule, soft 100 mg
- NEORAL capsule, soft 25 mg
- NEORAL capsule, soft 50 mg
- NEORAL oral solution 100 mg/ml
- SANDIMMUNE concentrate for solution for infusion 250 mg/5 ml
- SIMULECT powder for solution for injection 20 mg
- M01 - Antiinflamatorios y antirreumáticos
- VOLTAREN prolonged-release tablet 50 mg
- VOLTAREN RAPIDE coated tablet 50 mg
- VOLTAREN SR prolonged-release tablet 100 mg
- VOLTAREN SR prolonged-release tablet 75 mg
- VOLTAREN suppository 100 mg
- VOLTAREN suppository 50 mg
- M03 - Relajantes musculares
- LIORESAL DS tablet 20 mg
- LIORESAL solution for injection 0.05 mg/1 ml
- LIORESAL solution for injection 10 mg/20 ml
- LIORESAL solution for injection 10 mg/5 ml
- LIORESAL tablet 10 mg
- M05 - Preparados para el tratamiento de enfermedades óseas
- ACLASTA solution for infusion 5 mg/100 ml
- AREDIA powder and solvent for solution for infusion 30 mg+10 ml
- AREDIA powder and solvent for solution for infusion 90 mg+10 ml
- ZOMETA concentrate for solution for infusion 4 mg/5 ml
- N02 - Analgésicos
- FIORINAL C1/2 capsule, hard 30 mg+330 mg+50 mg+40 mg
- FIORINAL C1/4 capsule, hard 15 mg+330 mg+50 mg+40 mg
- FIORINAL capsule, hard 330 mg+50 mg+40 mg
- N03 - Antiepilépticos
- TEGRETOL chewable tablet 100 mg
- TEGRETOL chewable tablet 200 mg
- TEGRETOL oral suspension 2%
- TEGRETOL prolonged-release tablet 200 mg
- TEGRETOL prolonged-release tablet 400 mg
- TEGRETOL tablet 200 mg
- TRILEPTAL coated tablet 150 mg
- TRILEPTAL coated tablet 300 mg
- TRILEPTAL coated tablet 600 mg
- TRILEPTAL oral suspension 60 mg/ml
- N04 - Antiparkinsonianos
- COMTAN film-coated tablet 200 mg
- STALEVO film-coated tablet 100 mg+25 mg+200 mg
- STALEVO film-coated tablet 125 mg+31.25 mg+200 mg
- STALEVO film-coated tablet 150 mg+37.5 mg+200 mg
- STALEVO film-coated tablet 50 mg+12.5 mg+200 mg
- STALEVO film-coated tablet 75 mg+18.75 mg+200 mg
- N05 - Psicolépticos
- CLOZARIL tablet 100 mg
- CLOZARIL tablet 25 mg
- N06 - Psicoanalépticos
- EXELON capsule, hard 1.5 mg
- EXELON capsule, hard 3 mg
- EXELON capsule, hard 4.5 mg
- EXELON capsule, hard 6 mg
- EXELON oral solution 2 mg/ml
- EXELON transdermal patch 4.6 mg/24 h
- EXELON transdermal patch 9.5 mg/24 h
- RITALIN prolonged-release tablet 20 mg
- RITALIN tablet 10 mg
- RITALIN tablet 20 mg
- R03 - Agentes contra padecimientos obstructivos de las vías respiratorias
- FORADIL AEROLIZER inhalation powder, hard capsule 12 µg
- ONBREZ BREEZHALER inhalation powder, hard capsule 75 µg
- SEEBRI BREEZHALER inhalation powder, hard capsule 50 µg
- ULTIBRO BREEZHALER inhalation powder, hard capsule 110 µg+50 µg
- XOLAIR powder for solution for injection 150 mg
- S01 - Oftalmológicos
- LUCENTIS PREFILLED SYRINGE solution for injection 10 mg/ml
- V03 - Todos los demás preparados terapéuticos
- DESFERAL powder for solution for injection 2 g
- DESFERAL powder for solution for injection 500 mg
- EXJADE dispersible tablet 125 mg
- EXJADE dispersible tablet 250 mg
- EXJADE dispersible tablet 500 mg